Cyclooxygenase-2 - 10 Years later

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 2, 2002, Pages 367-375

  Hinz, Burkhard ^a   Brune, Kay ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; ISOENZYME; NONSTEROID ANTIINFLAMMATORY AGENT; PARECOXIB; ROFECOXIB; VALDECOXIB;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTHRITIS; BLEEDING; CANCER; CARCINOGENESIS; CARDIOVASCULAR SYSTEM; CATALYSIS; CENTRAL NERVOUS SYSTEM; DIGESTIVE SYSTEM ULCER; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; EYE; GASTROINTESTINAL TRACT; HUMAN; KIDNEY FUNCTION; PAIN; PRIORITY JOURNAL; REGULATORY MECHANISM; REPRODUCTION; REVIEW; THROMBOCYTE DYSFUNCTION;

ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SUBSTRATE SPECIFICITY;

EID: 0036156424     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.2.367     Document Type: Review

References (78)

1. Structure of the human cyclo-oxygenase-2 gene
2. 2
3. Upregulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation
4. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
5. Renal effects of COX-2-selective inhibitors
6. Cyclo-oxygenase inhibitors: New insights
7. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
8. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids
9. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases
10. Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body
11. 2 and interleukin-1β
12. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region
13. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
14. Effect of specific COX-2 inhibition in osteoarthritis of the knee: A 6-week double-blind, placebocontrolled, pilot study of rofecoxib
15. Cyclo-oxygenase products and atherothrombosis
16. Pharmakologie des kardiovaskulären systems: Die blutgefäβe
17. 2 synthase (cyclooxygenase) in human monocytes
18. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
19. Localization of prostaglandin H synthase type 2 protein and mRNA in term human fetal membranes and decidua
20. Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densa
21. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
22. Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E2 and nonsteroidal anti-inflammatory drugs
23. 2 up-regulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages
24. Anti-inflammatory - Antirheumatic drugs
25. 2 synthesis in murine macrophages
26. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach
27. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
28. Aspirin-like molecules that covalently inactivate cyclaoxygenase-2
29. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal anti-inflammatory drugs to potent and highly selective COX-2 inhibitors
30. Chemopreventive activity of celecoxib, a specific cyclaoxygenase-2 inhibitor, against colon carcinogenesis
31. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development
32. Inhibition of NF-κB by sodium salicylate and aspirin
33. Prostaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5′-flanking regulatory sequences
34. Structural basis for selective inhibition of cyclooxygenase -2 by anti-inflammatory agents
35. Cycloocygenase knockout mice. Models for elucidating isoform-specific functions
36. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
37. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide
38. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial
39. Cyclooxygenase-2 specificity and its clinical implications
40. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
41. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
42. Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes
43. 2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotidelinked prostaglandin receptors
44. Cyclooxygenase inhibitors: Discovery, selectivity and the future
45. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
46. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection
47. 2, cyclic AMP and non-steroidal anti-inflammatory drugs
48. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
49. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation
50. Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly
51. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils
52. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts
53. Cyclooxygenase and Alzheimer's disease: Implications for preventive initiatives to slow the progression of clinical dementia
54. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs
55. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprorein receptor knockout mice
56. Cyclooxygenase-2 and carcinogenesis
57. Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis
58. Etoricoxib (MK-0663) preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2
59. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
60. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity
61. The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term
62. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats
63. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety study
64. Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy
65. Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy
66. Pharmacological analysis of cyclooxygenase-1 in inflammation
67. Risk of Alzheimer's disease and duration of NSAID use
68. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: Cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress
69. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2
70. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
71. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
72. Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor
73. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
74. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
75. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
76. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine
77. Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids
78. Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa